Cel Sci Corporation (CVM)

[GD]

Regarding NWBO valuation after data PR, you only have to look at
BIIB, after even FDA defending BIIB's BLA, street is giving very
low valuation for chance of approval, but I thing FDA will approve
BIIB's drug in the end. I have admitted I have been wrong many months
about Geert's intent on tweets about timing of data PR, I do believe
you have a better sense of when, thank you for the heads up, I guess
I have to change old habits....